nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—breast cancer—Dexamethasone—multiple sclerosis	0.204	0.5	CpDpCtD
Estradiol—breast cancer—Betamethasone—multiple sclerosis	0.204	0.5	CpDpCtD
Estradiol—ALB—multiple sclerosis	0.061	1	CbGaD
Estradiol—Testosterone—Prednisolone—multiple sclerosis	0.037	1	CrCrCtD
Estradiol—CYP1B1—Mitoxantrone—multiple sclerosis	0.024	0.0739	CbGbCtD
Estradiol—SLC22A2—Cladribine—multiple sclerosis	0.0212	0.0652	CbGbCtD
Estradiol—SLC22A1—Cladribine—multiple sclerosis	0.0184	0.0567	CbGbCtD
Estradiol—ABCC10—Methotrexate—multiple sclerosis	0.0184	0.0567	CbGbCtD
Estradiol—SLCO1C1—Methotrexate—multiple sclerosis	0.0184	0.0567	CbGbCtD
Estradiol—AOX1—Methotrexate—multiple sclerosis	0.0174	0.0536	CbGbCtD
Estradiol—ABCG2—Cladribine—multiple sclerosis	0.0156	0.0482	CbGbCtD
Estradiol—SLCO1A2—Prednisolone—multiple sclerosis	0.0134	0.0412	CbGbCtD
Estradiol—SLCO1A2—Prednisone—multiple sclerosis	0.0126	0.0389	CbGbCtD
Estradiol—CYP1B1—Dexamethasone—multiple sclerosis	0.0124	0.0383	CbGbCtD
Estradiol—ABCG2—Mitoxantrone—multiple sclerosis	0.0114	0.0351	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—multiple sclerosis	0.0103	0.0316	CbGbCtD
Estradiol—SLC22A11—Methotrexate—multiple sclerosis	0.00948	0.0292	CbGbCtD
Estradiol—SLCO1A2—Dexamethasone—multiple sclerosis	0.00788	0.0243	CbGbCtD
Estradiol—ALB—Prednisone—multiple sclerosis	0.00652	0.0201	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—multiple sclerosis	0.00633	0.0195	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—multiple sclerosis	0.00598	0.0184	CbGbCtD
Estradiol—ABCG2—Dexamethasone—multiple sclerosis	0.00591	0.0182	CbGbCtD
Estradiol—ABCB1—Methylprednisolone—multiple sclerosis	0.00563	0.0174	CbGbCtD
Estradiol—SLC22A8—Methotrexate—multiple sclerosis	0.00552	0.017	CbGbCtD
Estradiol—CYP1A1—Dexamethasone—multiple sclerosis	0.00545	0.0168	CbGbCtD
Estradiol—CYP3A4—Fingolimod—multiple sclerosis	0.00524	0.0161	CbGbCtD
Estradiol—ABCG2—Methotrexate—multiple sclerosis	0.00475	0.0146	CbGbCtD
Estradiol—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.00436	0.0135	CbGbCtD
Estradiol—CYP3A7—Dexamethasone—multiple sclerosis	0.00436	0.0135	CbGbCtD
Estradiol—CYP2C19—Prednisone—multiple sclerosis	0.00423	0.013	CbGbCtD
Estradiol—ABCB1—Mitoxantrone—multiple sclerosis	0.00411	0.0127	CbGbCtD
Estradiol—ABCB1—Betamethasone—multiple sclerosis	0.00366	0.0113	CbGbCtD
Estradiol—ABCB1—Prednisolone—multiple sclerosis	0.00361	0.0111	CbGbCtD
Estradiol—ABCB1—Prednisone—multiple sclerosis	0.00341	0.0105	CbGbCtD
Estradiol—CYP3A4—Methylprednisolone—multiple sclerosis	0.00337	0.0104	CbGbCtD
Estradiol—CYP3A5—Dexamethasone—multiple sclerosis	0.00327	0.0101	CbGbCtD
Estradiol—ALB—Methotrexate—multiple sclerosis	0.00327	0.0101	CbGbCtD
Estradiol—CYP2C8—Dexamethasone—multiple sclerosis	0.00315	0.0097	CbGbCtD
Estradiol—CYP2C19—Dexamethasone—multiple sclerosis	0.00264	0.00814	CbGbCtD
Estradiol—CYP3A4—Triamcinolone—multiple sclerosis	0.00256	0.00789	CbGbCtD
Estradiol—CYP3A4—Mitoxantrone—multiple sclerosis	0.00246	0.00759	CbGbCtD
Estradiol—CYP2C9—Dexamethasone—multiple sclerosis	0.00219	0.00677	CbGbCtD
Estradiol—CYP3A4—Betamethasone—multiple sclerosis	0.00219	0.00677	CbGbCtD
Estradiol—CYP3A4—Prednisolone—multiple sclerosis	0.00216	0.00668	CbGbCtD
Estradiol—ABCB1—Dexamethasone—multiple sclerosis	0.00213	0.00657	CbGbCtD
Estradiol—CYP3A4—Prednisone—multiple sclerosis	0.00204	0.0063	CbGbCtD
Estradiol—ESRRB—retina—multiple sclerosis	0.0018	0.0911	CbGeAlD
Estradiol—ABCB1—Methotrexate—multiple sclerosis	0.00171	0.00528	CbGbCtD
Estradiol—CYP3A4—Dexamethasone—multiple sclerosis	0.00128	0.00394	CbGbCtD
Estradiol—GPER1—nervous system—multiple sclerosis	0.000673	0.034	CbGeAlD
Estradiol—GPER1—central nervous system—multiple sclerosis	0.000648	0.0327	CbGeAlD
Estradiol—GPER1—cerebellum—multiple sclerosis	0.000633	0.032	CbGeAlD
Estradiol—GPER1—brain—multiple sclerosis	0.000514	0.026	CbGeAlD
Estradiol—ESRRA—medulla oblongata—multiple sclerosis	0.000416	0.021	CbGeAlD
Estradiol—SLCO4A1—retina—multiple sclerosis	0.00039	0.0197	CbGeAlD
Estradiol—ESRRA—midbrain—multiple sclerosis	0.00038	0.0192	CbGeAlD
Estradiol—ESRRA—spinal cord—multiple sclerosis	0.000371	0.0188	CbGeAlD
Estradiol—ESR2—brainstem—multiple sclerosis	0.000358	0.0181	CbGeAlD
Estradiol—SHBG—brainstem—multiple sclerosis	0.000348	0.0176	CbGeAlD
Estradiol—SLCO1C1—midbrain—multiple sclerosis	0.000321	0.0162	CbGeAlD
Estradiol—SLCO1C1—spinal cord—multiple sclerosis	0.000313	0.0158	CbGeAlD
Estradiol—ESRRA—nervous system—multiple sclerosis	0.000313	0.0158	CbGeAlD
Estradiol—ESRRA—central nervous system—multiple sclerosis	0.000301	0.0152	CbGeAlD
Estradiol—ESRRA—cerebellum—multiple sclerosis	0.000294	0.0149	CbGeAlD
Estradiol—SLCO4A1—medulla oblongata—multiple sclerosis	0.000282	0.0142	CbGeAlD
Estradiol—SLCO1C1—nervous system—multiple sclerosis	0.000264	0.0133	CbGeAlD
Estradiol—SLCO4A1—midbrain—multiple sclerosis	0.000257	0.013	CbGeAlD
Estradiol—SLCO1C1—central nervous system—multiple sclerosis	0.000254	0.0129	CbGeAlD
Estradiol—SLCO4A1—spinal cord—multiple sclerosis	0.000251	0.0127	CbGeAlD
Estradiol—ESR1—brainstem—multiple sclerosis	0.000245	0.0124	CbGeAlD
Estradiol—ESRRA—brain—multiple sclerosis	0.000239	0.0121	CbGeAlD
Estradiol—ABCC10—medulla oblongata—multiple sclerosis	0.000234	0.0118	CbGeAlD
Estradiol—SLCO2B1—medulla oblongata—multiple sclerosis	0.000219	0.0111	CbGeAlD
Estradiol—ABCC10—midbrain—multiple sclerosis	0.000214	0.0108	CbGeAlD
Estradiol—SLCO4A1—nervous system—multiple sclerosis	0.000212	0.0107	CbGeAlD
Estradiol—ABCC10—spinal cord—multiple sclerosis	0.000209	0.0105	CbGeAlD
Estradiol—SLCO4A1—central nervous system—multiple sclerosis	0.000204	0.0103	CbGeAlD
Estradiol—SLCO1C1—brain—multiple sclerosis	0.000202	0.0102	CbGeAlD
Estradiol—SLCO1A2—medulla oblongata—multiple sclerosis	0.000202	0.0102	CbGeAlD
Estradiol—SLCO4A1—cerebellum—multiple sclerosis	0.000199	0.0101	CbGeAlD
Estradiol—SLCO2B1—spinal cord—multiple sclerosis	0.000195	0.00988	CbGeAlD
Estradiol—ESR2—nervous system—multiple sclerosis	0.000188	0.00949	CbGeAlD
Estradiol—SLCO1A2—midbrain—multiple sclerosis	0.000184	0.00932	CbGeAlD
Estradiol—ESR2—central nervous system—multiple sclerosis	0.000181	0.00913	CbGeAlD
Estradiol—SLCO1A2—spinal cord—multiple sclerosis	0.00018	0.00909	CbGeAlD
Estradiol—ESR2—cerebellum—multiple sclerosis	0.000177	0.00893	CbGeAlD
Estradiol—SHBG—central nervous system—multiple sclerosis	0.000176	0.00888	CbGeAlD
Estradiol—SHBG—cerebellum—multiple sclerosis	0.000172	0.00868	CbGeAlD
Estradiol—AOX1—cerebellum—multiple sclerosis	0.00017	0.00859	CbGeAlD
Estradiol—ABCC10—cerebellum—multiple sclerosis	0.000165	0.00836	CbGeAlD
Estradiol—SLCO2B1—nervous system—multiple sclerosis	0.000165	0.00832	CbGeAlD
Estradiol—SLCO4A1—brain—multiple sclerosis	0.000162	0.00818	CbGeAlD
Estradiol—SLCO2B1—central nervous system—multiple sclerosis	0.000159	0.00801	CbGeAlD
Estradiol—SLC22A1—nervous system—multiple sclerosis	0.000157	0.00795	CbGeAlD
Estradiol—AR—spinal cord—multiple sclerosis	0.000155	0.00785	CbGeAlD
Estradiol—SLCO2B1—cerebellum—multiple sclerosis	0.000155	0.00783	CbGeAlD
Estradiol—SLCO1A2—nervous system—multiple sclerosis	0.000152	0.00766	CbGeAlD
Estradiol—SLC22A1—central nervous system—multiple sclerosis	0.000152	0.00766	CbGeAlD
Estradiol—SLC22A3—nervous system—multiple sclerosis	0.00015	0.0076	CbGeAlD
Estradiol—SLCO1A2—central nervous system—multiple sclerosis	0.000146	0.00737	CbGeAlD
Estradiol—SLC22A3—central nervous system—multiple sclerosis	0.000145	0.00732	CbGeAlD
Estradiol—SLC22A8—nervous system—multiple sclerosis	0.000145	0.00731	CbGeAlD
Estradiol—ESR2—brain—multiple sclerosis	0.000143	0.00725	CbGeAlD
Estradiol—SLCO1A2—cerebellum—multiple sclerosis	0.000143	0.00721	CbGeAlD
Estradiol—SHBG—brain—multiple sclerosis	0.000139	0.00705	CbGeAlD
Estradiol—SLC22A8—central nervous system—multiple sclerosis	0.000139	0.00704	CbGeAlD
Estradiol—CYP1B1—nervous system—multiple sclerosis	0.000138	0.00699	CbGeAlD
Estradiol—AOX1—brain—multiple sclerosis	0.000138	0.00698	CbGeAlD
Estradiol—ABCG2—medulla oblongata—multiple sclerosis	0.000137	0.00693	CbGeAlD
Estradiol—ABCC10—brain—multiple sclerosis	0.000134	0.00679	CbGeAlD
Estradiol—CYP1B1—central nervous system—multiple sclerosis	0.000133	0.00673	CbGeAlD
Estradiol—AR—nervous system—multiple sclerosis	0.000131	0.00662	CbGeAlD
Estradiol—CYP1B1—cerebellum—multiple sclerosis	0.00013	0.00658	CbGeAlD
Estradiol—ESR1—nervous system—multiple sclerosis	0.000129	0.0065	CbGeAlD
Estradiol—AR—central nervous system—multiple sclerosis	0.000126	0.00637	CbGeAlD
Estradiol—SLCO2B1—brain—multiple sclerosis	0.000126	0.00636	CbGeAlD
Estradiol—ABCG2—midbrain—multiple sclerosis	0.000125	0.00633	CbGeAlD
Estradiol—ESR1—central nervous system—multiple sclerosis	0.000124	0.00625	CbGeAlD
Estradiol—ABCG2—spinal cord—multiple sclerosis	0.000122	0.00618	CbGeAlD
Estradiol—ESR1—cerebellum—multiple sclerosis	0.000121	0.00611	CbGeAlD
Estradiol—SLC22A1—brain—multiple sclerosis	0.00012	0.00608	CbGeAlD
Estradiol—SLCO1A2—brain—multiple sclerosis	0.000116	0.00585	CbGeAlD
Estradiol—ALB—brain—multiple sclerosis	0.000115	0.00582	CbGeAlD
Estradiol—SLC22A3—brain—multiple sclerosis	0.000115	0.00581	CbGeAlD
Estradiol—SLC22A8—brain—multiple sclerosis	0.000111	0.00559	CbGeAlD
Estradiol—CYP1B1—brain—multiple sclerosis	0.000106	0.00534	CbGeAlD
Estradiol—AR—brain—multiple sclerosis	0.0001	0.00506	CbGeAlD
Estradiol—ESR1—brain—multiple sclerosis	9.83e-05	0.00497	CbGeAlD
Estradiol—CYP1A1—nervous system—multiple sclerosis	9.78e-05	0.00494	CbGeAlD
Estradiol—ABCG2—cerebellum—multiple sclerosis	9.69e-05	0.0049	CbGeAlD
Estradiol—CYP1A1—central nervous system—multiple sclerosis	9.41e-05	0.00476	CbGeAlD
Estradiol—ABCB1—retina—multiple sclerosis	9.35e-05	0.00472	CbGeAlD
Estradiol—CYP2C8—brain—multiple sclerosis	8.09e-05	0.00409	CbGeAlD
Estradiol—ABCG2—brain—multiple sclerosis	7.87e-05	0.00398	CbGeAlD
Estradiol—CYP1A1—brain—multiple sclerosis	7.47e-05	0.00378	CbGeAlD
Estradiol—CYP3A4—nervous system—multiple sclerosis	7.17e-05	0.00362	CbGeAlD
Estradiol—CYP3A4—central nervous system—multiple sclerosis	6.91e-05	0.00349	CbGeAlD
Estradiol—ABCB1—medulla oblongata—multiple sclerosis	6.76e-05	0.00342	CbGeAlD
Estradiol—ABCB1—midbrain—multiple sclerosis	6.18e-05	0.00312	CbGeAlD
Estradiol—ABCB1—spinal cord—multiple sclerosis	6.03e-05	0.00305	CbGeAlD
Estradiol—ABCB1—nervous system—multiple sclerosis	5.08e-05	0.00257	CbGeAlD
Estradiol—ABCB1—central nervous system—multiple sclerosis	4.89e-05	0.00247	CbGeAlD
Estradiol—ABCB1—cerebellum—multiple sclerosis	4.78e-05	0.00241	CbGeAlD
Estradiol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	3.91e-05	0.000409	CcSEcCtD
Estradiol—Syncope—Betamethasone—multiple sclerosis	3.91e-05	0.000408	CcSEcCtD
Estradiol—Syncope—Dexamethasone—multiple sclerosis	3.91e-05	0.000408	CcSEcCtD
Estradiol—Infection—Triamcinolone—multiple sclerosis	3.89e-05	0.000407	CcSEcCtD
Estradiol—Infection—Methylprednisolone—multiple sclerosis	3.88e-05	0.000406	CcSEcCtD
Estradiol—ABCB1—brain—multiple sclerosis	3.88e-05	0.00196	CbGeAlD
Estradiol—Haematuria—Methotrexate—multiple sclerosis	3.87e-05	0.000404	CcSEcCtD
Estradiol—Shock—Triamcinolone—multiple sclerosis	3.85e-05	0.000403	CcSEcCtD
Estradiol—Insomnia—Prednisolone—multiple sclerosis	3.85e-05	0.000403	CcSEcCtD
Estradiol—Alopecia—Prednisone—multiple sclerosis	3.85e-05	0.000403	CcSEcCtD
Estradiol—Shock—Methylprednisolone—multiple sclerosis	3.85e-05	0.000402	CcSEcCtD
Estradiol—Hepatobiliary disease—Methotrexate—multiple sclerosis	3.84e-05	0.000401	CcSEcCtD
Estradiol—Nervous system disorder—Methylprednisolone—multiple sclerosis	3.83e-05	0.000401	CcSEcCtD
Estradiol—Loss of consciousness—Dexamethasone—multiple sclerosis	3.83e-05	0.0004	CcSEcCtD
Estradiol—Loss of consciousness—Betamethasone—multiple sclerosis	3.83e-05	0.0004	CcSEcCtD
Estradiol—Epistaxis—Methotrexate—multiple sclerosis	3.83e-05	0.0004	CcSEcCtD
Estradiol—Hypersensitivity—Mitoxantrone—multiple sclerosis	3.83e-05	0.0004	CcSEcCtD
Estradiol—Paraesthesia—Prednisolone—multiple sclerosis	3.83e-05	0.0004	CcSEcCtD
Estradiol—Tachycardia—Triamcinolone—multiple sclerosis	3.82e-05	0.0004	CcSEcCtD
Estradiol—Mental disorder—Prednisone—multiple sclerosis	3.82e-05	0.000399	CcSEcCtD
Estradiol—Nausea—Azathioprine—multiple sclerosis	3.82e-05	0.000399	CcSEcCtD
Estradiol—Tachycardia—Methylprednisolone—multiple sclerosis	3.82e-05	0.000399	CcSEcCtD
Estradiol—Skin disorder—Methylprednisolone—multiple sclerosis	3.8e-05	0.000397	CcSEcCtD
Estradiol—Erythema—Prednisone—multiple sclerosis	3.79e-05	0.000397	CcSEcCtD
Estradiol—Malnutrition—Prednisone—multiple sclerosis	3.79e-05	0.000397	CcSEcCtD
Estradiol—Hyperhidrosis—Triamcinolone—multiple sclerosis	3.79e-05	0.000396	CcSEcCtD
Estradiol—Hyperhidrosis—Methylprednisolone—multiple sclerosis	3.78e-05	0.000395	CcSEcCtD
Estradiol—Hypertension—Dexamethasone—multiple sclerosis	3.76e-05	0.000393	CcSEcCtD
Estradiol—Hypertension—Betamethasone—multiple sclerosis	3.76e-05	0.000393	CcSEcCtD
Estradiol—Asthenia—Mitoxantrone—multiple sclerosis	3.73e-05	0.00039	CcSEcCtD
Estradiol—Myalgia—Betamethasone—multiple sclerosis	3.71e-05	0.000388	CcSEcCtD
Estradiol—Myalgia—Dexamethasone—multiple sclerosis	3.71e-05	0.000388	CcSEcCtD
Estradiol—Anxiety—Dexamethasone—multiple sclerosis	3.7e-05	0.000386	CcSEcCtD
Estradiol—Anxiety—Betamethasone—multiple sclerosis	3.7e-05	0.000386	CcSEcCtD
Estradiol—Discomfort—Betamethasone—multiple sclerosis	3.66e-05	0.000383	CcSEcCtD
Estradiol—Discomfort—Dexamethasone—multiple sclerosis	3.66e-05	0.000383	CcSEcCtD
Estradiol—Haemoglobin—Methotrexate—multiple sclerosis	3.66e-05	0.000383	CcSEcCtD
Estradiol—Pain—Prednisolone—multiple sclerosis	3.64e-05	0.000381	CcSEcCtD
Estradiol—Haemorrhage—Methotrexate—multiple sclerosis	3.64e-05	0.000381	CcSEcCtD
Estradiol—Hepatitis—Methotrexate—multiple sclerosis	3.64e-05	0.000381	CcSEcCtD
Estradiol—Pharyngitis—Methotrexate—multiple sclerosis	3.61e-05	0.000378	CcSEcCtD
Estradiol—Urinary tract disorder—Methotrexate—multiple sclerosis	3.6e-05	0.000376	CcSEcCtD
Estradiol—Urethral disorder—Methotrexate—multiple sclerosis	3.57e-05	0.000373	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	3.57e-05	0.000373	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	3.56e-05	0.000372	CcSEcCtD
Estradiol—Oedema—Dexamethasone—multiple sclerosis	3.55e-05	0.000372	CcSEcCtD
Estradiol—Oedema—Betamethasone—multiple sclerosis	3.55e-05	0.000372	CcSEcCtD
Estradiol—Anaphylactic shock—Betamethasone—multiple sclerosis	3.55e-05	0.000372	CcSEcCtD
Estradiol—Anaphylactic shock—Dexamethasone—multiple sclerosis	3.55e-05	0.000372	CcSEcCtD
Estradiol—Diarrhoea—Mitoxantrone—multiple sclerosis	3.55e-05	0.000371	CcSEcCtD
Estradiol—Insomnia—Triamcinolone—multiple sclerosis	3.54e-05	0.00037	CcSEcCtD
Estradiol—Insomnia—Methylprednisolone—multiple sclerosis	3.54e-05	0.00037	CcSEcCtD
Estradiol—Infection—Betamethasone—multiple sclerosis	3.53e-05	0.000369	CcSEcCtD
Estradiol—Infection—Dexamethasone—multiple sclerosis	3.53e-05	0.000369	CcSEcCtD
Estradiol—Ill-defined disorder—Prednisone—multiple sclerosis	3.52e-05	0.000368	CcSEcCtD
Estradiol—Paraesthesia—Triamcinolone—multiple sclerosis	3.52e-05	0.000368	CcSEcCtD
Estradiol—Feeling abnormal—Prednisolone—multiple sclerosis	3.51e-05	0.000367	CcSEcCtD
Estradiol—Paraesthesia—Methylprednisolone—multiple sclerosis	3.51e-05	0.000367	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—multiple sclerosis	3.51e-05	0.000367	CcSEcCtD
Estradiol—Shock—Betamethasone—multiple sclerosis	3.5e-05	0.000366	CcSEcCtD
Estradiol—Shock—Dexamethasone—multiple sclerosis	3.5e-05	0.000366	CcSEcCtD
Estradiol—Dyspnoea—Triamcinolone—multiple sclerosis	3.49e-05	0.000365	CcSEcCtD
Estradiol—Nervous system disorder—Betamethasone—multiple sclerosis	3.49e-05	0.000364	CcSEcCtD
Estradiol—Nervous system disorder—Dexamethasone—multiple sclerosis	3.49e-05	0.000364	CcSEcCtD
Estradiol—Agitation—Prednisone—multiple sclerosis	3.49e-05	0.000364	CcSEcCtD
Estradiol—Tachycardia—Dexamethasone—multiple sclerosis	3.47e-05	0.000363	CcSEcCtD
Estradiol—Tachycardia—Betamethasone—multiple sclerosis	3.47e-05	0.000363	CcSEcCtD
Estradiol—Angioedema—Prednisone—multiple sclerosis	3.47e-05	0.000362	CcSEcCtD
Estradiol—Dyspepsia—Triamcinolone—multiple sclerosis	3.45e-05	0.000361	CcSEcCtD
Estradiol—Erythema multiforme—Methotrexate—multiple sclerosis	3.44e-05	0.00036	CcSEcCtD
Estradiol—Dyspepsia—Methylprednisolone—multiple sclerosis	3.44e-05	0.00036	CcSEcCtD
Estradiol—Hyperhidrosis—Betamethasone—multiple sclerosis	3.44e-05	0.000359	CcSEcCtD
Estradiol—Hyperhidrosis—Dexamethasone—multiple sclerosis	3.44e-05	0.000359	CcSEcCtD
Estradiol—Malaise—Prednisone—multiple sclerosis	3.42e-05	0.000358	CcSEcCtD
Estradiol—Vertigo—Prednisone—multiple sclerosis	3.41e-05	0.000356	CcSEcCtD
Estradiol—Eye disorder—Methotrexate—multiple sclerosis	3.4e-05	0.000356	CcSEcCtD
Estradiol—Syncope—Prednisone—multiple sclerosis	3.4e-05	0.000356	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—multiple sclerosis	3.4e-05	0.000355	CcSEcCtD
Estradiol—Urticaria—Prednisolone—multiple sclerosis	3.38e-05	0.000354	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—multiple sclerosis	3.38e-05	0.000353	CcSEcCtD
Estradiol—Fatigue—Triamcinolone—multiple sclerosis	3.38e-05	0.000353	CcSEcCtD
Estradiol—Fatigue—Methylprednisolone—multiple sclerosis	3.37e-05	0.000352	CcSEcCtD
Estradiol—Pain—Triamcinolone—multiple sclerosis	3.35e-05	0.00035	CcSEcCtD
Estradiol—Loss of consciousness—Prednisone—multiple sclerosis	3.33e-05	0.000349	CcSEcCtD
Estradiol—Angiopathy—Methotrexate—multiple sclerosis	3.3e-05	0.000345	CcSEcCtD
Estradiol—Vomiting—Mitoxantrone—multiple sclerosis	3.3e-05	0.000345	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—multiple sclerosis	3.29e-05	0.000344	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—multiple sclerosis	3.28e-05	0.000343	CcSEcCtD
Estradiol—Hypertension—Prednisone—multiple sclerosis	3.28e-05	0.000342	CcSEcCtD
Estradiol—Rash—Mitoxantrone—multiple sclerosis	3.27e-05	0.000342	CcSEcCtD
Estradiol—Dermatitis—Mitoxantrone—multiple sclerosis	3.27e-05	0.000342	CcSEcCtD
Estradiol—Chills—Methotrexate—multiple sclerosis	3.27e-05	0.000342	CcSEcCtD
Estradiol—Headache—Mitoxantrone—multiple sclerosis	3.25e-05	0.00034	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	3.24e-05	0.000339	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	3.24e-05	0.000339	CcSEcCtD
Estradiol—Myalgia—Prednisone—multiple sclerosis	3.23e-05	0.000338	CcSEcCtD
Estradiol—Arthralgia—Prednisone—multiple sclerosis	3.23e-05	0.000338	CcSEcCtD
Estradiol—Feeling abnormal—Triamcinolone—multiple sclerosis	3.23e-05	0.000338	CcSEcCtD
Estradiol—Feeling abnormal—Methylprednisolone—multiple sclerosis	3.22e-05	0.000337	CcSEcCtD
Estradiol—Anxiety—Prednisone—multiple sclerosis	3.22e-05	0.000336	CcSEcCtD
Estradiol—Alopecia—Methotrexate—multiple sclerosis	3.22e-05	0.000336	CcSEcCtD
Estradiol—Insomnia—Betamethasone—multiple sclerosis	3.22e-05	0.000336	CcSEcCtD
Estradiol—Insomnia—Dexamethasone—multiple sclerosis	3.22e-05	0.000336	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	3.21e-05	0.000335	CcSEcCtD
Estradiol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	3.2e-05	0.000334	CcSEcCtD
Estradiol—Paraesthesia—Dexamethasone—multiple sclerosis	3.19e-05	0.000334	CcSEcCtD
Estradiol—Paraesthesia—Betamethasone—multiple sclerosis	3.19e-05	0.000334	CcSEcCtD
Estradiol—Discomfort—Prednisone—multiple sclerosis	3.19e-05	0.000334	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—multiple sclerosis	3.19e-05	0.000334	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—multiple sclerosis	3.17e-05	0.000331	CcSEcCtD
Estradiol—Erythema—Methotrexate—multiple sclerosis	3.17e-05	0.000331	CcSEcCtD
Estradiol—Hypersensitivity—Prednisolone—multiple sclerosis	3.14e-05	0.000328	CcSEcCtD
Estradiol—Dyspepsia—Dexamethasone—multiple sclerosis	3.13e-05	0.000327	CcSEcCtD
Estradiol—Dyspepsia—Betamethasone—multiple sclerosis	3.13e-05	0.000327	CcSEcCtD
Estradiol—Urticaria—Triamcinolone—multiple sclerosis	3.11e-05	0.000325	CcSEcCtD
Estradiol—Urticaria—Methylprednisolone—multiple sclerosis	3.11e-05	0.000325	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—multiple sclerosis	3.1e-05	0.000325	CcSEcCtD
Estradiol—Body temperature increased—Triamcinolone—multiple sclerosis	3.1e-05	0.000324	CcSEcCtD
Estradiol—Oedema—Prednisone—multiple sclerosis	3.1e-05	0.000324	CcSEcCtD
Estradiol—Anaphylactic shock—Prednisone—multiple sclerosis	3.1e-05	0.000324	CcSEcCtD
Estradiol—Abdominal pain—Methylprednisolone—multiple sclerosis	3.09e-05	0.000323	CcSEcCtD
Estradiol—Decreased appetite—Betamethasone—multiple sclerosis	3.09e-05	0.000323	CcSEcCtD
Estradiol—Decreased appetite—Dexamethasone—multiple sclerosis	3.09e-05	0.000323	CcSEcCtD
Estradiol—Nausea—Mitoxantrone—multiple sclerosis	3.08e-05	0.000322	CcSEcCtD
Estradiol—Infection—Prednisone—multiple sclerosis	3.08e-05	0.000322	CcSEcCtD
Estradiol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	3.07e-05	0.000321	CcSEcCtD
Estradiol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	3.07e-05	0.000321	CcSEcCtD
Estradiol—Back pain—Methotrexate—multiple sclerosis	3.07e-05	0.000321	CcSEcCtD
Estradiol—Fatigue—Betamethasone—multiple sclerosis	3.06e-05	0.00032	CcSEcCtD
Estradiol—Fatigue—Dexamethasone—multiple sclerosis	3.06e-05	0.00032	CcSEcCtD
Estradiol—Shock—Prednisone—multiple sclerosis	3.05e-05	0.000318	CcSEcCtD
Estradiol—Pain—Dexamethasone—multiple sclerosis	3.04e-05	0.000318	CcSEcCtD
Estradiol—Pain—Betamethasone—multiple sclerosis	3.04e-05	0.000318	CcSEcCtD
Estradiol—Nervous system disorder—Prednisone—multiple sclerosis	3.04e-05	0.000317	CcSEcCtD
Estradiol—Tachycardia—Prednisone—multiple sclerosis	3.02e-05	0.000316	CcSEcCtD
Estradiol—Skin disorder—Prednisone—multiple sclerosis	3.01e-05	0.000314	CcSEcCtD
Estradiol—Hyperhidrosis—Prednisone—multiple sclerosis	2.99e-05	0.000313	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—multiple sclerosis	2.94e-05	0.000308	CcSEcCtD
Estradiol—Feeling abnormal—Betamethasone—multiple sclerosis	2.93e-05	0.000306	CcSEcCtD
Estradiol—Feeling abnormal—Dexamethasone—multiple sclerosis	2.93e-05	0.000306	CcSEcCtD
Estradiol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	2.91e-05	0.000304	CcSEcCtD
Estradiol—Gastrointestinal pain—Betamethasone—multiple sclerosis	2.91e-05	0.000304	CcSEcCtD
Estradiol—Hypersensitivity—Triamcinolone—multiple sclerosis	2.89e-05	0.000302	CcSEcCtD
Estradiol—Hypersensitivity—Methylprednisolone—multiple sclerosis	2.88e-05	0.000301	CcSEcCtD
Estradiol—Malaise—Methotrexate—multiple sclerosis	2.86e-05	0.000299	CcSEcCtD
Estradiol—Vertigo—Methotrexate—multiple sclerosis	2.85e-05	0.000298	CcSEcCtD
Estradiol—Urticaria—Betamethasone—multiple sclerosis	2.82e-05	0.000295	CcSEcCtD
Estradiol—Urticaria—Dexamethasone—multiple sclerosis	2.82e-05	0.000295	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Prednisone—multiple sclerosis	2.82e-05	0.000295	CcSEcCtD
Estradiol—Dizziness—Prednisolone—multiple sclerosis	2.82e-05	0.000295	CcSEcCtD
Estradiol—Asthenia—Triamcinolone—multiple sclerosis	2.81e-05	0.000294	CcSEcCtD
Estradiol—Abdominal pain—Betamethasone—multiple sclerosis	2.81e-05	0.000294	CcSEcCtD
Estradiol—Abdominal pain—Dexamethasone—multiple sclerosis	2.81e-05	0.000294	CcSEcCtD
Estradiol—Body temperature increased—Betamethasone—multiple sclerosis	2.81e-05	0.000294	CcSEcCtD
Estradiol—Body temperature increased—Dexamethasone—multiple sclerosis	2.81e-05	0.000294	CcSEcCtD
Estradiol—Asthenia—Methylprednisolone—multiple sclerosis	2.8e-05	0.000293	CcSEcCtD
Estradiol—Insomnia—Prednisone—multiple sclerosis	2.8e-05	0.000293	CcSEcCtD
Estradiol—Paraesthesia—Prednisone—multiple sclerosis	2.78e-05	0.000291	CcSEcCtD
Estradiol—Pruritus—Triamcinolone—multiple sclerosis	2.77e-05	0.00029	CcSEcCtD
Estradiol—Cough—Methotrexate—multiple sclerosis	2.77e-05	0.000289	CcSEcCtD
Estradiol—Pruritus—Methylprednisolone—multiple sclerosis	2.77e-05	0.000289	CcSEcCtD
Estradiol—Dyspepsia—Prednisone—multiple sclerosis	2.73e-05	0.000285	CcSEcCtD
Estradiol—Chest pain—Methotrexate—multiple sclerosis	2.7e-05	0.000282	CcSEcCtD
Estradiol—Myalgia—Methotrexate—multiple sclerosis	2.7e-05	0.000282	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—multiple sclerosis	2.7e-05	0.000282	CcSEcCtD
Estradiol—Decreased appetite—Prednisone—multiple sclerosis	2.69e-05	0.000281	CcSEcCtD
Estradiol—Rash—Prednisolone—multiple sclerosis	2.69e-05	0.000281	CcSEcCtD
Estradiol—Dermatitis—Prednisolone—multiple sclerosis	2.68e-05	0.000281	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	2.68e-05	0.00028	CcSEcCtD
Estradiol—Diarrhoea—Methylprednisolone—multiple sclerosis	2.67e-05	0.00028	CcSEcCtD
Estradiol—Fatigue—Prednisone—multiple sclerosis	2.67e-05	0.000279	CcSEcCtD
Estradiol—Headache—Prednisolone—multiple sclerosis	2.67e-05	0.000279	CcSEcCtD
Estradiol—Discomfort—Methotrexate—multiple sclerosis	2.67e-05	0.000279	CcSEcCtD
Estradiol—Constipation—Prednisone—multiple sclerosis	2.65e-05	0.000277	CcSEcCtD
Estradiol—Confusional state—Methotrexate—multiple sclerosis	2.61e-05	0.000273	CcSEcCtD
Estradiol—Dizziness—Triamcinolone—multiple sclerosis	2.59e-05	0.000271	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—multiple sclerosis	2.59e-05	0.000271	CcSEcCtD
Estradiol—Dizziness—Methylprednisolone—multiple sclerosis	2.59e-05	0.00027	CcSEcCtD
Estradiol—Infection—Methotrexate—multiple sclerosis	2.57e-05	0.000269	CcSEcCtD
Estradiol—Feeling abnormal—Prednisone—multiple sclerosis	2.55e-05	0.000267	CcSEcCtD
Estradiol—Asthenia—Betamethasone—multiple sclerosis	2.55e-05	0.000267	CcSEcCtD
Estradiol—Asthenia—Dexamethasone—multiple sclerosis	2.55e-05	0.000267	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—multiple sclerosis	2.54e-05	0.000265	CcSEcCtD
Estradiol—Gastrointestinal pain—Prednisone—multiple sclerosis	2.53e-05	0.000265	CcSEcCtD
Estradiol—Nausea—Prednisolone—multiple sclerosis	2.53e-05	0.000265	CcSEcCtD
Estradiol—Pruritus—Dexamethasone—multiple sclerosis	2.52e-05	0.000263	CcSEcCtD
Estradiol—Pruritus—Betamethasone—multiple sclerosis	2.52e-05	0.000263	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—multiple sclerosis	2.51e-05	0.000263	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—multiple sclerosis	2.5e-05	0.000262	CcSEcCtD
Estradiol—Vomiting—Triamcinolone—multiple sclerosis	2.49e-05	0.00026	CcSEcCtD
Estradiol—Vomiting—Methylprednisolone—multiple sclerosis	2.49e-05	0.00026	CcSEcCtD
Estradiol—Rash—Triamcinolone—multiple sclerosis	2.47e-05	0.000258	CcSEcCtD
Estradiol—Dermatitis—Triamcinolone—multiple sclerosis	2.47e-05	0.000258	CcSEcCtD
Estradiol—Rash—Methylprednisolone—multiple sclerosis	2.46e-05	0.000258	CcSEcCtD
Estradiol—Dermatitis—Methylprednisolone—multiple sclerosis	2.46e-05	0.000257	CcSEcCtD
Estradiol—Urticaria—Prednisone—multiple sclerosis	2.46e-05	0.000257	CcSEcCtD
Estradiol—Headache—Triamcinolone—multiple sclerosis	2.45e-05	0.000257	CcSEcCtD
Estradiol—Headache—Methylprednisolone—multiple sclerosis	2.45e-05	0.000256	CcSEcCtD
Estradiol—Body temperature increased—Prednisone—multiple sclerosis	2.45e-05	0.000256	CcSEcCtD
Estradiol—Abdominal pain—Prednisone—multiple sclerosis	2.45e-05	0.000256	CcSEcCtD
Estradiol—Diarrhoea—Betamethasone—multiple sclerosis	2.43e-05	0.000254	CcSEcCtD
Estradiol—Diarrhoea—Dexamethasone—multiple sclerosis	2.43e-05	0.000254	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	2.36e-05	0.000246	CcSEcCtD
Estradiol—Dizziness—Dexamethasone—multiple sclerosis	2.35e-05	0.000246	CcSEcCtD
Estradiol—Dizziness—Betamethasone—multiple sclerosis	2.35e-05	0.000246	CcSEcCtD
Estradiol—Insomnia—Methotrexate—multiple sclerosis	2.34e-05	0.000245	CcSEcCtD
Estradiol—Nausea—Triamcinolone—multiple sclerosis	2.33e-05	0.000243	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—multiple sclerosis	2.32e-05	0.000243	CcSEcCtD
Estradiol—Nausea—Methylprednisolone—multiple sclerosis	2.32e-05	0.000243	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—multiple sclerosis	2.31e-05	0.000241	CcSEcCtD
Estradiol—Somnolence—Methotrexate—multiple sclerosis	2.3e-05	0.00024	CcSEcCtD
Estradiol—Hypersensitivity—Prednisone—multiple sclerosis	2.28e-05	0.000238	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—multiple sclerosis	2.28e-05	0.000238	CcSEcCtD
Estradiol—Vomiting—Betamethasone—multiple sclerosis	2.26e-05	0.000236	CcSEcCtD
Estradiol—Vomiting—Dexamethasone—multiple sclerosis	2.26e-05	0.000236	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—multiple sclerosis	2.25e-05	0.000235	CcSEcCtD
Estradiol—Rash—Dexamethasone—multiple sclerosis	2.24e-05	0.000234	CcSEcCtD
Estradiol—Rash—Betamethasone—multiple sclerosis	2.24e-05	0.000234	CcSEcCtD
Estradiol—Dermatitis—Dexamethasone—multiple sclerosis	2.24e-05	0.000234	CcSEcCtD
Estradiol—Dermatitis—Betamethasone—multiple sclerosis	2.24e-05	0.000234	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.23e-05	0.000234	CcSEcCtD
Estradiol—Fatigue—Methotrexate—multiple sclerosis	2.23e-05	0.000233	CcSEcCtD
Estradiol—Headache—Dexamethasone—multiple sclerosis	2.23e-05	0.000233	CcSEcCtD
Estradiol—Headache—Betamethasone—multiple sclerosis	2.23e-05	0.000233	CcSEcCtD
Estradiol—Asthenia—Prednisone—multiple sclerosis	2.22e-05	0.000232	CcSEcCtD
Estradiol—Pain—Methotrexate—multiple sclerosis	2.21e-05	0.000231	CcSEcCtD
Estradiol—Pruritus—Prednisone—multiple sclerosis	2.19e-05	0.000229	CcSEcCtD
Estradiol—Feeling abnormal—Methotrexate—multiple sclerosis	2.13e-05	0.000223	CcSEcCtD
Estradiol—Diarrhoea—Prednisone—multiple sclerosis	2.12e-05	0.000221	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—multiple sclerosis	2.12e-05	0.000221	CcSEcCtD
Estradiol—Nausea—Betamethasone—multiple sclerosis	2.11e-05	0.000221	CcSEcCtD
Estradiol—Nausea—Dexamethasone—multiple sclerosis	2.11e-05	0.000221	CcSEcCtD
Estradiol—Urticaria—Methotrexate—multiple sclerosis	2.06e-05	0.000215	CcSEcCtD
Estradiol—Dizziness—Prednisone—multiple sclerosis	2.05e-05	0.000214	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—multiple sclerosis	2.05e-05	0.000214	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—multiple sclerosis	2.05e-05	0.000214	CcSEcCtD
Estradiol—Vomiting—Prednisone—multiple sclerosis	1.97e-05	0.000206	CcSEcCtD
Estradiol—Rash—Prednisone—multiple sclerosis	1.95e-05	0.000204	CcSEcCtD
Estradiol—Dermatitis—Prednisone—multiple sclerosis	1.95e-05	0.000204	CcSEcCtD
Estradiol—Headache—Prednisone—multiple sclerosis	1.94e-05	0.000203	CcSEcCtD
Estradiol—Hypersensitivity—Methotrexate—multiple sclerosis	1.91e-05	0.000199	CcSEcCtD
Estradiol—Asthenia—Methotrexate—multiple sclerosis	1.86e-05	0.000194	CcSEcCtD
Estradiol—Nausea—Prednisone—multiple sclerosis	1.84e-05	0.000192	CcSEcCtD
Estradiol—Pruritus—Methotrexate—multiple sclerosis	1.83e-05	0.000191	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—multiple sclerosis	1.77e-05	0.000185	CcSEcCtD
Estradiol—Dizziness—Methotrexate—multiple sclerosis	1.71e-05	0.000179	CcSEcCtD
Estradiol—Vomiting—Methotrexate—multiple sclerosis	1.65e-05	0.000172	CcSEcCtD
Estradiol—Rash—Methotrexate—multiple sclerosis	1.63e-05	0.000171	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—multiple sclerosis	1.63e-05	0.00017	CcSEcCtD
Estradiol—Headache—Methotrexate—multiple sclerosis	1.62e-05	0.000169	CcSEcCtD
Estradiol—Nausea—Methotrexate—multiple sclerosis	1.54e-05	0.000161	CcSEcCtD
Estradiol—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.99e-06	0.000166	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—RRM1—multiple sclerosis	8.98e-06	0.000166	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	8.95e-06	0.000165	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.91e-06	0.000165	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.89e-06	0.000164	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.87e-06	0.000164	CbGpPWpGaD
Estradiol—AOX1—Disease—HLA-A—multiple sclerosis	8.85e-06	0.000164	CbGpPWpGaD
Estradiol—CYP2C19—Biological oxidations—POMC—multiple sclerosis	8.73e-06	0.000161	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—SRM—multiple sclerosis	8.59e-06	0.000159	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	8.58e-06	0.000158	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	8.58e-06	0.000158	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—POMC—multiple sclerosis	8.58e-06	0.000158	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	8.56e-06	0.000158	CbGpPWpGaD
Estradiol—ABCB1—Allograft Rejection—TNF—multiple sclerosis	8.55e-06	0.000158	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	8.54e-06	0.000158	CbGpPWpGaD
Estradiol—ESR2—Generic Transcription Pathway—MYC—multiple sclerosis	8.43e-06	0.000156	CbGpPWpGaD
Estradiol—SLCO1B3—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.43e-06	0.000156	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—BCHE—multiple sclerosis	8.38e-06	0.000155	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—RRM1—multiple sclerosis	8.37e-06	0.000155	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	8.37e-06	0.000155	CbGpPWpGaD
Estradiol—SLC22A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.27e-06	0.000153	CbGpPWpGaD
Estradiol—AOX1—Disease—APOE—multiple sclerosis	8.27e-06	0.000153	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—STAT3—multiple sclerosis	8.26e-06	0.000153	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—BCHE—multiple sclerosis	8.23e-06	0.000152	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—RGS1—multiple sclerosis	8.18e-06	0.000151	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	8.11e-06	0.00015	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	8.11e-06	0.00015	CbGpPWpGaD
Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	7.97e-06	0.000147	CbGpPWpGaD
Estradiol—CYP2C9—Biological oxidations—POMC—multiple sclerosis	7.96e-06	0.000147	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.92e-06	0.000146	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.88e-06	0.000145	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—GPC5—multiple sclerosis	7.85e-06	0.000145	CbGpPWpGaD
Estradiol—ESRRA—Metabolism—ALB—multiple sclerosis	7.82e-06	0.000144	CbGpPWpGaD
Estradiol—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.81e-06	0.000144	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—GPR65—multiple sclerosis	7.76e-06	0.000143	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.74e-06	0.000143	CbGpPWpGaD
Estradiol—ESR1—Signaling by ERBB4—IL6—multiple sclerosis	7.72e-06	0.000143	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—MYC—multiple sclerosis	7.68e-06	0.000142	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—TGFB1—multiple sclerosis	7.66e-06	0.000141	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.64e-06	0.000141	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.61e-06	0.00014	CbGpPWpGaD
Estradiol—ALB—Hemostasis—ITGA4—multiple sclerosis	7.57e-06	0.00014	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IFNB1—multiple sclerosis	7.51e-06	0.000139	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—MAPK1—multiple sclerosis	7.51e-06	0.000139	CbGpPWpGaD
Estradiol—AOX1—Disease—CD80—multiple sclerosis	7.47e-06	0.000138	CbGpPWpGaD
Estradiol—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.46e-06	0.000138	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	7.43e-06	0.000137	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	7.43e-06	0.000137	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—GPC5—multiple sclerosis	7.41e-06	0.000137	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP27B1—multiple sclerosis	7.39e-06	0.000137	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP24A1—multiple sclerosis	7.39e-06	0.000137	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—PGR—multiple sclerosis	7.37e-06	0.000136	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—SRM—multiple sclerosis	7.34e-06	0.000136	CbGpPWpGaD
Estradiol—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.28e-06	0.000135	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.26e-06	0.000134	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.22e-06	0.000133	CbGpPWpGaD
Estradiol—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	7.22e-06	0.000133	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL13—multiple sclerosis	7.09e-06	0.000131	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCR1—multiple sclerosis	7.09e-06	0.000131	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.97e-06	0.000129	CbGpPWpGaD
Estradiol—AOX1—Metabolism—APOE—multiple sclerosis	6.92e-06	0.000128	CbGpPWpGaD
Estradiol—CYP1A2—Biological oxidations—POMC—multiple sclerosis	6.8e-06	0.000126	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—GPC5—multiple sclerosis	6.8e-06	0.000126	CbGpPWpGaD
Estradiol—ALB—Metabolism—GPC5—multiple sclerosis	6.76e-06	0.000125	CbGpPWpGaD
Estradiol—AR—Gene Expression—VDR—multiple sclerosis	6.68e-06	0.000123	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.65e-06	0.000123	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	6.63e-06	0.000123	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	6.63e-06	0.000123	CbGpPWpGaD
Estradiol—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.62e-06	0.000122	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—BCHE—multiple sclerosis	6.58e-06	0.000122	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.53e-06	0.000121	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—RRM1—multiple sclerosis	6.5e-06	0.00012	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.48e-06	0.00012	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP27B1—multiple sclerosis	6.48e-06	0.00012	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP24A1—multiple sclerosis	6.48e-06	0.00012	CbGpPWpGaD
Estradiol—ESRRA—Gene Expression—MYC—multiple sclerosis	6.38e-06	0.000118	CbGpPWpGaD
Estradiol—AOX1—Disease—TYK2—multiple sclerosis	6.31e-06	0.000117	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—BCHE—multiple sclerosis	6.14e-06	0.000113	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—RRM1—multiple sclerosis	6.14e-06	0.000113	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GPC5—multiple sclerosis	6.07e-06	0.000112	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.06e-06	0.000112	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	6.05e-06	0.000112	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	6.05e-06	0.000112	CbGpPWpGaD
Estradiol—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	5.99e-06	0.000111	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.96e-06	0.00011	CbGpPWpGaD
Estradiol—AOX1—Metabolism—POMC—multiple sclerosis	5.95e-06	0.00011	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GPC5—multiple sclerosis	5.92e-06	0.000109	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.91e-06	0.000109	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	5.88e-06	0.000109	CbGpPWpGaD
Estradiol—GPER1—Signaling Pathways—IL6—multiple sclerosis	5.77e-06	0.000107	CbGpPWpGaD
Estradiol—NR1I2—Gene Expression—MYC—multiple sclerosis	5.77e-06	0.000107	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—BCHE—multiple sclerosis	5.73e-06	0.000106	CbGpPWpGaD
Estradiol—AOX1—Disease—CD4—multiple sclerosis	5.71e-06	0.000105	CbGpPWpGaD
Estradiol—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.66e-06	0.000105	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—SRM—multiple sclerosis	5.66e-06	0.000105	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—RRM1—multiple sclerosis	5.63e-06	0.000104	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—BCHE—multiple sclerosis	5.63e-06	0.000104	CbGpPWpGaD
Estradiol—ALB—Metabolism—RRM1—multiple sclerosis	5.6e-06	0.000103	CbGpPWpGaD
Estradiol—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	5.58e-06	0.000103	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GPC5—multiple sclerosis	5.53e-06	0.000102	CbGpPWpGaD
Estradiol—AR—Generic Transcription Pathway—MYC—multiple sclerosis	5.52e-06	0.000102	CbGpPWpGaD
Estradiol—AOX1—Metabolism—ALB—multiple sclerosis	5.42e-06	0.0001	CbGpPWpGaD
Estradiol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.25e-06	9.69e-05	CbGpPWpGaD
Estradiol—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.24e-06	9.69e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—BCHE—multiple sclerosis	5.21e-06	9.63e-05	CbGpPWpGaD
Estradiol—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.19e-06	9.59e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IL2RA—multiple sclerosis	5.17e-06	9.55e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	5.17e-06	9.55e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	5.17e-06	9.55e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—BCHE—multiple sclerosis	5.17e-06	9.54e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—BCHE—multiple sclerosis	5.16e-06	9.53e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—VDR—multiple sclerosis	5.15e-06	9.51e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL3—multiple sclerosis	5.05e-06	9.34e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.05e-06	9.33e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—APOE—multiple sclerosis	5.04e-06	9.31e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—RRM1—multiple sclerosis	5.03e-06	9.29e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—APOE—multiple sclerosis	4.95e-06	9.14e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—RRM1—multiple sclerosis	4.91e-06	9.06e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PTGER4—multiple sclerosis	4.87e-06	8.99e-05	CbGpPWpGaD
Estradiol—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	4.84e-06	8.93e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—BCHE—multiple sclerosis	4.81e-06	8.88e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PGR—multiple sclerosis	4.79e-06	8.85e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.77e-06	8.8e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GPC5—multiple sclerosis	4.73e-06	8.73e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCR3—multiple sclerosis	4.7e-06	8.68e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CD28—multiple sclerosis	4.65e-06	8.6e-05	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.59e-06	8.47e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—RRM1—multiple sclerosis	4.58e-06	8.47e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCR2—multiple sclerosis	4.57e-06	8.44e-05	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.53e-06	8.36e-05	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.52e-06	8.34e-05	CbGpPWpGaD
Estradiol—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.5e-06	8.31e-05	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.43e-06	8.18e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—STAT3—multiple sclerosis	4.42e-06	8.16e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.37e-06	8.07e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.35e-06	8.03e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—POMC—multiple sclerosis	4.33e-06	8e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—POMC—multiple sclerosis	4.25e-06	7.85e-05	CbGpPWpGaD
Estradiol—ESR1—Generic Transcription Pathway—MYC—multiple sclerosis	4.25e-06	7.85e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CNR1—multiple sclerosis	4.22e-06	7.79e-05	CbGpPWpGaD
Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.22e-06	7.79e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—MYC—multiple sclerosis	4.1e-06	7.58e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.09e-06	7.56e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—TGFB1—multiple sclerosis	4.09e-06	7.56e-05	CbGpPWpGaD
Estradiol—ESR2—Gene Expression—MYC—multiple sclerosis	4.06e-06	7.5e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—MAPK1—multiple sclerosis	4.02e-06	7.42e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3.99e-06	7.37e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3.99e-06	7.37e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—APOE—multiple sclerosis	3.96e-06	7.32e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—ALB—multiple sclerosis	3.95e-06	7.29e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—RRM1—multiple sclerosis	3.92e-06	7.24e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.9e-06	7.2e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—ALB—multiple sclerosis	3.88e-06	7.16e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CXCL10—multiple sclerosis	3.8e-06	7.02e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.75e-06	6.93e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—BCHE—multiple sclerosis	3.74e-06	6.9e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.73e-06	6.9e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.73e-06	6.89e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—APOE—multiple sclerosis	3.7e-06	6.83e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.65e-06	6.74e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.56e-06	6.57e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—BCHE—multiple sclerosis	3.53e-06	6.52e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—APOE—multiple sclerosis	3.45e-06	6.37e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.42e-06	6.32e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—POMC—multiple sclerosis	3.4e-06	6.28e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—APOE—multiple sclerosis	3.39e-06	6.26e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.35e-06	6.19e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CD86—multiple sclerosis	3.32e-06	6.13e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL5—multiple sclerosis	3.27e-06	6.04e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—BCHE—multiple sclerosis	3.24e-06	5.98e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—BCHE—multiple sclerosis	3.22e-06	5.94e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—POMC—multiple sclerosis	3.18e-06	5.86e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—APOE—multiple sclerosis	3.14e-06	5.79e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—APOE—multiple sclerosis	3.11e-06	5.74e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—APOE—multiple sclerosis	3.1e-06	5.73e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—ALB—multiple sclerosis	3.1e-06	5.73e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—IL6—multiple sclerosis	3.09e-06	5.7e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.06e-06	5.64e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.06e-06	5.64e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.04e-06	5.61e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—IL2—multiple sclerosis	3.03e-06	5.6e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SPP1—multiple sclerosis	3.03e-06	5.59e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.02e-06	5.58e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—POMC—multiple sclerosis	2.96e-06	5.47e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCR5—multiple sclerosis	2.95e-06	5.44e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—POMC—multiple sclerosis	2.91e-06	5.37e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2RA—multiple sclerosis	2.9e-06	5.36e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—ALB—multiple sclerosis	2.89e-06	5.35e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—APOE—multiple sclerosis	2.89e-06	5.34e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.89e-06	5.33e-05	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.84e-06	5.24e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—BCHE—multiple sclerosis	2.82e-06	5.21e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.79e-06	5.15e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—ALB—multiple sclerosis	2.7e-06	4.99e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—POMC—multiple sclerosis	2.69e-06	4.98e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—APOE—multiple sclerosis	2.68e-06	4.95e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—POMC—multiple sclerosis	2.67e-06	4.93e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—POMC—multiple sclerosis	2.67e-06	4.92e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MYC—multiple sclerosis	2.66e-06	4.91e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—ALB—multiple sclerosis	2.65e-06	4.9e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—BCHE—multiple sclerosis	2.63e-06	4.86e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.61e-06	4.82e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—POMC—multiple sclerosis	2.49e-06	4.59e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—ALB—multiple sclerosis	2.46e-06	4.54e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—ALB—multiple sclerosis	2.43e-06	4.5e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—ALB—multiple sclerosis	2.43e-06	4.49e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CD80—multiple sclerosis	2.42e-06	4.47e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.38e-06	4.4e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TGFB1—multiple sclerosis	2.36e-06	4.37e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—MAPK1—multiple sclerosis	2.32e-06	4.28e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—POMC—multiple sclerosis	2.3e-06	4.25e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ALB—multiple sclerosis	2.27e-06	4.18e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCL2—multiple sclerosis	2.25e-06	4.16e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.25e-06	4.16e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—APOE—multiple sclerosis	2.25e-06	4.15e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—APOE—multiple sclerosis	2.12e-06	3.92e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MYC—multiple sclerosis	2.05e-06	3.78e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TYK2—multiple sclerosis	2.05e-06	3.78e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—APOE—multiple sclerosis	1.95e-06	3.59e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—APOE—multiple sclerosis	1.94e-06	3.57e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—POMC—multiple sclerosis	1.93e-06	3.57e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—POMC—multiple sclerosis	1.82e-06	3.37e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ALB—multiple sclerosis	1.76e-06	3.25e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—APOE—multiple sclerosis	1.74e-06	3.21e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.74e-06	3.21e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL2—multiple sclerosis	1.7e-06	3.14e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—APOE—multiple sclerosis	1.7e-06	3.13e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—POMC—multiple sclerosis	1.67e-06	3.09e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ALB—multiple sclerosis	1.66e-06	3.07e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—POMC—multiple sclerosis	1.66e-06	3.07e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MMP9—multiple sclerosis	1.61e-06	2.98e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—APOE—multiple sclerosis	1.58e-06	2.93e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ALB—multiple sclerosis	1.52e-06	2.82e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—POMC—multiple sclerosis	1.49e-06	2.76e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—POMC—multiple sclerosis	1.46e-06	2.69e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—STAT3—multiple sclerosis	1.43e-06	2.65e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—POMC—multiple sclerosis	1.36e-06	2.51e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ALB—multiple sclerosis	1.36e-06	2.51e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—APOE—multiple sclerosis	1.35e-06	2.5e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MYC—multiple sclerosis	1.33e-06	2.46e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ALB—multiple sclerosis	1.33e-06	2.45e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TGFB1—multiple sclerosis	1.33e-06	2.45e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MAPK1—multiple sclerosis	1.3e-06	2.4e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ALB—multiple sclerosis	1.24e-06	2.29e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—POMC—multiple sclerosis	1.16e-06	2.15e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ALB—multiple sclerosis	1.06e-06	1.96e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—APOE—multiple sclerosis	1.04e-06	1.93e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—IL6—multiple sclerosis	1e-06	1.85e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—POMC—multiple sclerosis	8.97e-07	1.66e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALB—multiple sclerosis	8.18e-07	1.51e-05	CbGpPWpGaD
